Drugs / ZhenQi FuZheng granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06427577 | Jun 2024 → Jun 2025 overdue | allergic rhinitis | The First Affiliated Hospital with Nanjing Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZhenQi FuZheng granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06427577 ↗ |
| Known as | ShiDaiYangGuang | “ZhenQi FuZheng granules (ShiDaiYangGuang)” NCT06427577 ↗ |
| Route | Oral | “Oral orally for 4 weeks.” NCT06427577 ↗ |